Rankings
▼
Calendar
BCYC FY 2019 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+93.4% YoY
Gross Profit
-$12M
-85.1% margin
Operating Income
-$26M
-190.6% margin
Net Income
-$31M
-221.8% margin
EPS (Diluted)
$-2.77
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$30M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$110M
Total Liabilities
$17M
Stockholders' Equity
$93M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$7M
+93.4%
Gross Profit
-$12M
-$14M
+13.8%
Operating Income
-$26M
-$22M
-20.9%
Net Income
-$31M
-$22M
-40.1%
← Q4 2018
All Quarters
Q1 2019 →